Pedro Gaspar: The Role of CD4⁺ T Cells in APS
Pedro Gaspar, Co-Chair at International Society on Thrombosis and Haemostasis (ISTH), Medical Doctor at North Lisbon University Hospital Centre, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Autoimmunity Reviews:
“Happy to share our latest review in Autoimmunity Reviews: ‘Dysregulation of helper, regulatory, and follicular CD4⁺ T cells in antiphospholipid syndrome.’
This article provides a comprehensive overview of current evidence supporting the role of CD4⁺ T-cell subsets – including Treg, Tfh, and Tfr cells – in the pathogenesis of antiphospholipid syndrome, highlighting emerging mechanisms and potential therapeutic targets.
A great collaborative effort.
Many thanks to all co-authors.”
Title: Dysregulation of helper, regulatory, and follicular CD4+ T cells in primary antiphospholipid syndrome: Immunopathology and implications for targeted immunomodulatory therapy
Authors: Pedro Gaspar, Filipa Ribeiro, Válter R Fonseca, Vasco C Romão, João E Fonseca, Luis Graca

Stay updated with Hemostasis Today.
-
Oct 21, 2026, 03:18Stephen D. Coombs: Superficial Venous Thrombosis in Athletes and Importance of Early Recognition and Referral
-
Oct 21, 2026, 02:52Aymar Akilimali: Bleeding During Anticoagulation as a Potential Signal of Occult Cancer
-
Oct 21, 2026, 00:58Anees Ur Rahman: Completing a Two-Week Clinical Rotation at Haemophilia Treatment Centre Rawalpindi
-
Oct 21, 2026, 00:56Caitlyn Mooney: Pulmonary Embolism in Athletes, Recognition and Return to Sport
-
Oct 21, 2026, 00:54Hani Karrar: Pleased to Share Our Review on Emicizumab in Hemophilia A Management
-
Oct 21, 2026, 00:53Akshay Sharma: HSCT Leads to Sustained Improvements in Sickle Cell Cardiomyopathy for Up to 3 Years
-
Oct 21, 2026, 00:51Prateek Meena: The F. A. T. R. N. Mnemonic for Recognizing TTP
-
Oct 20, 2026, 23:51Registration Is Open for WFH CCS 2027 – World Federation of Hemophilia
-
Oct 20, 2026, 23:44Edward Lee Carter: AF in Nursing Homes – When Stroke Risk Scores Tell Only Part of the Story